세계의 장 관리 시스템 시장 예측(2024-2029년)

The global bowel management systems market is projected to grow at a CAGR of 4.13% to reach US$1,077.824 million by 2029, from US$811.927 million in 2022.

The bowel management system consists of medical gadgets, procedures, and interventions meant to assist individuals with impaired bowel control including those with neurological clutter such as neurogenic bowel dysfunction, spinal cord-related injuries, and numerous types of sclerosis. The main goal of these systems is to observe, analyze, and monitor the movement of the bowel, avoid fecal incontinence or stoppage, and upgrade the quality of life for these people. These systems may incorporate dietary adjustments, medicines, and the utilization of therapeutic gadgets such as rectal suppositories, bowel purges, or bowel irrigation systems.

The worldwide bowel management systems industry incorporates the manufacturing, distribution, and sales of items and solutions outlined to address bowel dysfunction and progress bowel management. Variables contributing to this market expansion are majorly due to the predominance of neurological clutters, the growing senior-age populace, innovative technological progressions, a patient-centric approach, and rising healthcare use.

Neurological disorders, like spinal cord injuries, different sclerosis, and certain neurological clutters, can result in bowel brokenness, driving the request for bowel administration arrangements. Technological progressions offer moved forward viability, consolation, and comfort for people overseeing bowel dysfunction in their daily lives.

Market Drivers:

• The increasing number of bowel diseases and the geriatric population are anticipated to boost the bowel management systems market.

The bowel management system helps patients maintain clean, uncontaminated skin by assisting with the treatment of fecal irregularity. The device is a soft catheter that is inserted into the rectum to contain and divert fecal waste. The surge in availability of technologically advanced devices for fecal management and the rise in the geriatric population.

The increase in fecal inconsistency-related disorders is the major factor that is driving the market for bowel management systems to grow. Furthermore, increased awareness of the availability of these devices, combined with the introduction of new devices that address many unserved needs contributes to the bowel management system market's growth.

According to the AANP data of April 2024, Irritable bowel syndrome (IBS), a chronic gastrointestinal condition affecting 25 to 45 million people in the US, can limit their ability to work, attend school, and maintain relationships. Despite affecting 5 to 10% of the global population, 75% of those with IBS may be undiagnosed. Patients seeking medical treatment may wait up to four years before seeing their healthcare provider. Furthermore, favorable reimbursement scenarios in developed economies, as well as technological advancements in bowel management systems, are driving the market growth.

The problem of fecal inconsistency is more prevalent among adults, which will bolster the bowel management systems market.

As individuals age, cognitive function declines, and alertness and control over bloody functions decrease, which is one reason geriatric individuals require assistance. Fecal irregularity, especially within the aging population, maybe a developing concern, driving the request for bowel administration frameworks. Components contributing to this involve the global maturing populace, persistent conditions such as neurological diseases, diabetes, and certain gastrointestinal illnesses, which can cause bowel irregularity.

Additionally, post-surgical and medical treatments can lead to temporary or chronic bowel dysfunction, making it crucial for individuals to manage these issues effectively. The bowel management systems market is expected to grow due to these factors and the need to address the growing issue of fecal inconsistency in the aging population. A large number of adults have fecal incontinence, which is fueling up the requirement for bowel management frameworks.

There is an increment within the utilization of colostomy bags as the number of people enduring illnesses and complications related to the bowel is expanding. In expansion, infections like irritable bowel disorder are more common among the aging population. According to the Centers for Disease Control and Prevention data of April 2022, IBD, including Crohn's disease and ulcerative colitis, affects 1.3% of the US adult population, including 3.1 million adults.

The North American region is predicted to dominate the market share.

The North American region is evaluated to increase essentially in industry share over the projected period owing to the increasing number of severe infections, well-positioned healthcare systems, and well-developed healthcare framework. Moreover, the increasing awareness among patients with respect to the hazards of different bowel issues is additionally anticipated to contribute to this region's market expansion.

Due to an increment in the number of severe illnesses like intestinal cancer and colorectal cancer among the populace, the North American countries are anticipated to hold moderate market size and contribute to its expansion over the estimated period. As a result, the chance of bowel diseases influencing the geriatric population is expanding.

Key Developments:

• February 2024- Coloplast launched Peristeen(R) Light, a transanal irrigation device designed to help people with bowel disorders, including chronic constipation and fecal incontinence. Peristeen Light is based on 20 years of experience from Coloplast's high-volume gadget, Peristeen Plus. It is instinctive, easy to utilize, and collected in fair two steps with a delicate, adaptable catheter.
• April 2022- Microbiotica received funding from the Crohn's & Colitis Foundation to develop a Live Bacterial Therapeutic (LBT) for ulcerative colitis (UC). The development of MB310, a fully defined LBT containing 10 bacterial species, is being funded by the Crohn's & Colitis Foundation's IBD Ventures program in preparation for cGMP manufacture and an investigational new drug application. Immune homeostasis can be restored and important UC disease pathology addressed by MB310.
• February 2022- Coloplast, a leading manufacturer of stoma care products, launched SenSura(R) Mio in Singapore, the first Southeast Asian country to introduce this innovative product.

Company Product:

• StimRouter(R) Neuromodulation System- Bioness, Inc. has received FDA approval and CE mark for its "StimRouter(R) Neuromodulation System," a medical device for treating peripheral nerve pain. The system, available in Europe, allows physicians to treat fecal or bowel incontinence by inserting a small implant into the tibial nerve near the ankle. The device is minimally invasive and easier to implant near the nerve Tibialis.
• BARD DIGNISHEILD Stool Management System - BD, a leading global medical equipment company, offers the "BARD DIGNISHEILD Stool Management System" to protect delicate tissues from damage caused by leakage, pressure, or friction. The system incorporates a catheter tube assembly, a 60cc syringe, a collection bag, and a lubricating jelly. Additional products include an odor eliminator and a tube clamp. The system helps patients avoid exposure, tissue damage, and odor.
• Rectobag - B. Braun Melsungen AG, a leading medical product manufacturer, offers a range of products under its Fecal Incontinence & Bowel Management segment, including a Rectobag and a Rectal Catheter. The Rectobag is a closed system used for repeated intestinal salvage and diagnostics, featuring a conical connector, bore transfer tube, and a 10 cm length with a closing clamp. The Irrigation Catheter, also known as a rectal catheter, has a color-coded cone fitting, a closed rounded tip, and two laterally positioned eyes.

Market Segmentation:

Global Bowel Management Systems Market is segmented and analyzed as below:

By Product

• Colostomy Bags
• Irrigation Systems
• Nerve Modulation Devices
• Others

By Patient Type

• Adults
• Paediatric

By End-User

• Hospitals
• Ambulatory Centers
• Home Care

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• UK
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• Israel
• Others
• Asia Pacific
• China
• Japan
• South Korea
• India
• Thailand
• Taiwan
• Indonesia
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Processes

3. EXECUTIVE SUMMARY

• 3.1. Key Findings

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis
• 4.5. Analyst View

5. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET BY PRODUCT

• 5.1. Introduction
• 5.2. Colostomy Bags
  • 5.2.1. Market Opportunities and Trends
  • 5.2.2. Growth Prospects
  • 5.2.3. Geographic Lucrativeness
• 5.3. Irrigation Systems
  • 5.3.1. Market Opportunities and Trends
  • 5.3.2. Growth Prospects
  • 5.3.3. Geographic Lucrativeness
• 5.4. Nerve Modulation Devices
  • 5.4.1. Market Opportunities and Trends
  • 5.4.2. Growth Prospects
  • 5.4.3. Geographic Lucrativeness
• 5.5. Others
  • 5.5.1. Market Opportunities and Trends
  • 5.5.2. Growth Prospects
  • 5.5.3. Geographic Lucrativeness

6. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET BY PATIENT TYPE

• 6.1. Introduction
• 6.2. Adults
  • 6.2.1. Market Opportunities and Trends
  • 6.2.2. Growth Prospects
  • 6.2.3. Geographic Lucrativeness
• 6.3. Paediatric
  • 6.3.1. Market Opportunities and Trends
  • 6.3.2. Growth Prospects
  • 6.3.3. Geographic Lucrativeness

7. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals
  • 7.2.1. Market Opportunities and Trends
  • 7.2.2. Growth Prospects
  • 7.2.3. Geographic Lucrativeness
• 7.3. Ambulatory Centers
  • 7.3.1. Market Opportunities and Trends
  • 7.3.2. Growth Prospects
  • 7.3.3. Geographic Lucrativeness
• 7.4. Home Care
  • 7.4.1. Market Opportunities and Trends
  • 7.4.2. Growth Prospects
  • 7.4.3. Geographic Lucrativeness

8. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Product
  • 8.2.2. By Patient Type
  • 8.2.3. By End-User
  • 8.2.4. By Country
    • 8.2.4.1. USA
      • 8.2.4.1.1. Market Opportunities and Trends
      • 8.2.4.1.2. Growth Prospects
    • 8.2.4.2. Canada
      • 8.2.4.2.1. Market Opportunities and Trends
      • 8.2.4.2.2. Growth Prospects
    • 8.2.4.3. Mexico
      • 8.2.4.3.1. Market Opportunities and Trends
      • 8.2.4.3.2. Growth Prospects
• 8.3. South America
  • 8.3.1. By Product
  • 8.3.2. By Patient Type
  • 8.3.3. By End-User
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
      • 8.3.4.1.1. Market Opportunities and Trends
      • 8.3.4.1.2. Growth Prospects
    • 8.3.4.2. Argentina
      • 8.3.4.2.1. Market Opportunities and Trends
      • 8.3.4.2.2. Growth Prospects
    • 8.3.4.3. Others
      • 8.3.4.3.1. Market Opportunities and Trends
      • 8.3.4.3.2. Growth Prospects
• 8.4. Europe
  • 8.4.1. By Product
  • 8.4.2. By Patient Type
  • 8.4.3. By End-User
  • 8.4.4. By Country
    • 8.4.4.1. Germany
      • 8.4.4.1.1. Market Opportunities and Trends
      • 8.4.4.1.2. Growth Prospects
    • 8.4.4.2. France
      • 8.4.4.2.1. Market Opportunities and Trends
      • 8.4.4.2.2. Growth Prospects
    • 8.4.4.3. UK
      • 8.4.4.3.1. Market Opportunities and Trends
      • 8.4.4.3.2. Growth Prospects
    • 8.4.4.4. Spain
      • 8.4.4.4.1. Market Opportunities and Trends
      • 8.4.4.4.2. Growth Prospects
    • 8.4.4.5. Others
      • 8.4.4.5.1. Market Opportunities and Trends
      • 8.4.4.5.2. Growth Prospects
• 8.5. Middle East and Africa
  • 8.5.1. By Product
  • 8.5.2. By Patient Type
  • 8.5.3. By End-User
  • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
      • 8.5.4.1.1. Market Opportunities and Trends
      • 8.5.4.1.2. Growth Prospects
    • 8.5.4.2. Israel
      • 8.5.4.2.1. Market Opportunities and Trends
      • 8.5.4.2.2. Growth Prospects
    • 8.5.4.3. Others
      • 8.5.4.3.1. Market Opportunities and Trends
      • 8.5.4.3.2. Growth Prospects
• 8.6. Asia Pacific
  • 8.6.1. By Product
  • 8.6.2. By Patient Type
  • 8.6.3. By End-User
  • 8.6.4. By Country
    • 8.6.4.1. China
      • 8.6.4.1.1. Market Opportunities and Trends
      • 8.6.4.1.2. Growth Prospects
    • 8.6.4.2. Japan
      • 8.6.4.2.1. Market Opportunities and Trends
      • 8.6.4.2.2. Growth Prospects
    • 8.6.4.3. South Korea
      • 8.6.4.3.1. Market Opportunities and Trends
      • 8.6.4.3.2. Growth Prospects
    • 8.6.4.4. India
      • 8.6.4.4.1. Market Opportunities and Trends
      • 8.6.4.4.2. Growth Prospects
    • 8.6.4.5. Thailand
      • 8.6.4.5.1. Market Opportunities and Trends
      • 8.6.4.5.2. Growth Prospects
    • 8.6.4.6. Taiwan
      • 8.6.4.6.1. Market Opportunities and Trends
      • 8.6.4.6.2. Growth Prospects
    • 8.6.4.7. Indonesia
      • 8.6.4.7.1. Market Opportunities and Trends
      • 8.6.4.7.2. Growth Prospects
    • 8.6.4.8. Others
      • 8.6.4.8.1. Market Opportunities and Trends
      • 8.6.4.8.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Cogentix Medical
• 10.2. Hollister Incorporated
• 10.3. Mbh-International A/S
• 10.4. Mederi Therapeutics Inc
• 10.5. B. Braun Melsungen AG
• 10.6. Aquaflush Medical Limited
• 10.7. Consure
• 10.8. Wellspect health care
• 10.9. ConvaTec Group Plc.
• 10.10. ProSys International Ltd.